AbbVie submits venetoclax sNDA for acute myeloid leukaemia
AbbVie has submitted a supplemental new drug application (sNDA) to the US Food and Drug Administration (FDA) for the use…
acute myeloid leukaemia
AbbVie has submitted a supplemental new drug application (sNDA) to the US Food and Drug Administration (FDA) for the use…